# BARDA Securing Anthrax Immunity For the Elderly

> **NCT03518125** · PHASE2 · COMPLETED · sponsor: **Biomedical Advanced Research and Development Authority** · enrollment: 305 (actual)

## Conditions studied

- Anthrax

## Interventions

- **BIOLOGICAL:** BioThrax
- **BIOLOGICAL:** AV7909
- **DRUG:** Sodium chloride injection USP, 0.9% (placebo)

## Key facts

- **NCT ID:** NCT03518125
- **Lead sponsor:** Biomedical Advanced Research and Development Authority
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-09
- **Primary completion:** 2019-01-14
- **Final completion:** 2019-12-09
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2020-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03518125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03518125, "BARDA Securing Anthrax Immunity For the Elderly". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03518125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*